NASDAQ: ZLAB       Zai Lab Ltd ADR
Last Price Today's Change   Day's Range   Trading Volume
119.25   -4.80 (3.87%)  119.00 - 124.04  813,100


Avg Volume (4 weeks):383,797
4 Weeks Range:119.00 - 152.82
4 Weeks Price Volatility (%):
52 Weeks Range:72.76 - 193.54
52 Weeks Price Volatility (%):
Average Price Target:-


No recent Headlines for this stock.

Business Background

Zai Lab Ltd is a biopharmaceutical company focusing on discovering or licensing, developing and commercializing proprietary therapeutics that address areas of unmet medical need including in the fields of oncology, autoimmune and infectious diseases. The pipeline of proprietary drug candidates of the company includes ZL-2306 for treatment across multiple solid tumor types including ovarian and certain types of breast and lung cancers; ZL-2401 which is an antibiotic in a new class of tetracycline derivatives; and ZL-2301 is an oral, small molecule which targets HCC. The other product candidate includes Fugan, ZL-2302, and ZL-1101. The company operates through the single segment being Developing and commercializing proprietary therapeutics.

  Be the first to like this.

I3 Messenger
Individual or Group chat with anyone on I3investor

4049  5735  857  657 

Top 10 Active Counters
 RWLK 2.59+1.29 
 SQQQ 8.13-0.02 
 LCID 26.615+2.545 
 NNVC 6.19+2.40 
 UBER 44.525+4.735 
 SPY 433.63-0.41 
 CEI 1.60+0.05 
 FAMI 0.2130.00 
 CRVS 8.53+2.36 
 UVXY 25.86-1.45